In previous studies, ALK was involved in tumor progression of several cancers, including anaplastic large cell lymphomas, ALK-positive diffuse large B-cell lymphomas, inflammatory myofibroblastic tumors, and non-small cell lung carcinomas [15]. This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.